ArticleThe Journal of investigative dermatology2015

Inhibition of EGFR Tyrosine Kinase by Erlotinib Prevents Sclerodermatous Graft-Versus-Host Disease in a Mouse Model.

Florence Morin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.